Hide Board Information

Show Board Information

CTGX Mining, Inc. CHCX

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/13/2015 10:59:21 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

CTGX Mining, Inc. (OTCMRKTS: CHCX) Stock Message Board

1. CHCX Company Profile

    

2. CHCX Time & Sales

    

3. CHCX Recent News

    

4. CHCX Filings

    

5. CHCX Financials

    

6. CHCX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	Hey, this board doesn't get enough attention.	alj14	01/13/2015 10:59:21 AM
6	We will just have to see with CHCX. Not much news	alj14	01/08/2015 5:27:10 PM
5	CHCX suddenly cam back to life today, with	alj14	12/26/2014 6:45:58 PM
4	CHCX 0.20 Real-Time Bid & Ask 0.085 /	leahanne	07/29/2014 8:00:45 PM
3	CHCX Stock Charts Tuesday, July 29, 2014 7:56:42	chartguy89	07/29/2014 7:56:35 PM
2	CHCX 0.08 Stock Charts $CHCX 1 Month Chart	chartguy89	03/06/2014 10:08:23 AM
1	CHCX Stock Charts Monday, February 24, 2014 at	chartguy89	02/24/2014 11:08:01 AM

Recent Articles

• Replimune Group's Stock Drop Sparks Investor Class Action Suit
• Investing in Murphy USA: An Insightful Decade of Growth
• Oceana's SeaChange Event Surpasses $1.7 Million for Oceans
• Slide Insurance Prepares for Earnings Call with Investors
• Molina Healthcare Faces Investigation: What Investors Need to Know
• A Decade of Growth: Stride's Impressive Stock Journey
• NOV Inc. Highlights Growth Amidst Economic Challenges in 2025
• Live Oak Bancshares Announces New Depositary Share Offering Details
• Community Healthcare Earnings Report: Insights and Outlook
• Exploring Clearwater Paper's Upcoming Earnings Insights
• ConnectOne Bancorp: Analyzing Upcoming Earnings Announcement
• Tilray's Financial Report: Mixed Results with Promising Forecasts
• FIBRA Prologis Reveals Impressive Second Quarter Growth
• NOV Inc. Reports Impressive Q2 2025 Financial Performance
• Vice President JD Vance's Tour at Metallus Steel Plant
• Reddit, Inc. Investors May Join Securities Fraud Action
• Globe Life Receives Closure on DOJ Investigation, Focuses on Growth
• BCAN Offers Support to Deion Sanders Amid Cancer Battle
• Discover How Altria, Mastercard, and Ulta Can Build Your Wealth
• Live Oak Bancshares Announces New Depositary Share Offering
• Slide Insurance Holdings Set to Share Q2 Results Soon
• Earnings Anticipation for LendingClub: Key Insights Ahead
• Twin Hospitality Group's Exciting Financial Updates for Investors
• NexPoint Residential: What to Expect from Earnings Ahead
• Expectations for Teladoc Health's Upcoming Earnings Report
• Understanding Tetra Technologies: Prior Earnings and Future Prospects
• Insights on Expro Group Holdings' Quarterly Performance Ahead
• Understanding Okeanis Eco Tankers and Its Earnings Outlook
• Surge Energy Reports Strong Q2 Results: Production Forecast Up
• Grupo Comercial Chedraui Reports Strong Second Quarter Results
• Emerging Opportunities in Alpha-synuclein Inhibitors Market Growth
• FIBRA Prologis Reports Strong Q2 2025 Earnings Insights
• Key Insights for Investors Ahead of Meta Platforms Q2 Earnings
• Abercrombie & Fitch: An In-Depth Look at Its Value Prospects
• Strategic Decisions Following Bankruptcy: Nano Dimension Insights
• Qualigen Therapeutics Updates on Nasdaq Listing Compliance Efforts
• FAT Brands Set to Reveal Second Quarter Financial Insights
• Unlocking Long-Term Growth: The Journey of Texas Instruments
• Grupo Comercial Chedraui Reports Strong Second Quarter Performance
• Empowering Recovery: Join the Opioid Summit for Veterans
• Market Insights: Key Earnings Reports and Trends Ahead
• Understanding the Centene Corporation Class Action Lawsuit
• Understanding the Recent Legal Challenges Facing Reddit, Inc.
• Investors Rally Behind Hims & Hers Amid Class Action Lawsuit
• Brown & Brown, Inc. Reports Significant Growth in Q2 2025
• Investor Alert: Legal Action for Sarepta Therapeutics Losses
• Upcoming Earnings Call for Maravai LifeSciences: Key Insights
• Class Action Notice: Hims & Hers Investors Can Recover Losses
• Investors Alert: Hims & Hers Faces Class Action Lawsuit Risks
• Sarepta Therapeutics Facing Class Action Lawsuit Amid Concerns